- Notification that Annual Report will be submitted late (NT 10-K)
29 Setembro 2010 - 5:04PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
|
|
|
|
|
|
(Check one):
|
|
þ
Form 10-K
o
Form 20-F
o
Form 11-K
o
Form 10-Q
o
Form N-SAR
o
Form N-CSR
|
|
|
|
|
|
|
|
|
For Period Ended:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
o
Transition Report on Form 10-K
|
|
|
|
|
|
|
|
|
|
o
Transition Report on Form 20-F
|
|
|
|
|
|
|
|
|
|
o
Transition Report on Form 11-K
|
|
|
|
|
|
|
|
|
|
o
Transition Report on Form 10-Q
|
|
|
|
|
|
|
|
|
|
o
Transition Report on Form N-SAR
|
|
|
|
|
|
|
|
|
|
For the Transition Period Ended:
|
|
|
|
|
|
|
|
|
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify the Item(s) to which
the notification relates:
TABLE OF CONTENTS
PART I REGISTRANT INFORMATION
Full Name of Registrant
Former Name if Applicable
435 Devon Park Drive, Building 100
Address of Principal Executive Office
(Street and Number)
City, State and Zip Code
PART II RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
|
|
|
|
|
|
þ
|
|
|
(a)
|
|
The reason described in reasonable detail in Part III of this form could not be
eliminated without unreasonable effort or expense
|
|
|
|
|
|
|
(b)
|
|
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
|
|
|
|
|
|
|
|
(c)
|
|
The accountants statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART III NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
(Attach extra Sheets if Needed)
NARRATIVE
Escalon Medical Corp. (the Company) will not be able to
file its report on Form 10-K for the period ended June 30, 2010 within the prescribed time period without unreasonable effort and expense. The Company intends to file its Form 10-K within the 15-day extension
period afforded by SEC Rule 12b-25 under the Securities Exchange Act of 1934, as amended.
The Company needs additional time to ensure the disclosure related
to discontinued operations is complete. As was the case in the Form
10-K for the fiscal year ended June 30, 2009, the Companys Form
10-K for fiscal year ended June 30, 2010 will include an explanatory paragraph from the Companys
independent registered public accounting firm expressing substantial doubt about the Companys ability to continue as a going concern.
PART IV OTHER INFORMATION
(1)
|
|
Name and telephone number of person to contact in regard to this notification
|
|
|
|
|
|
Robert OConnor
|
|
610
|
|
688-6830
|
(Name)
|
|
(Area Code)
|
|
(Telephone Number)
|
(2)
|
|
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
|
|
|
Yes
þ
No
o
|
|
(3)
|
|
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
|
|
|
Yes
o
No
þ
|
|
|
|
|
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
|
|
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
Date
|
|
September 29, 2010
|
|
By
|
|
/s/ Richard J. DePiano, Sr., CEO
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly
authorized representative. The name and title of the person signing the form shall be typed or
printed beneath the signature. If the statement is signed on behalf of the registrant by an
authorized representative (other than an executive officer), evidence of the representatives
authority to sign on behalf of the registrant shall be filed with the form.
ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C.
1001).
GENERAL INSTRUCTIONS
1.
|
|
This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the
General Rules and Regulations under the Securities Exchange Act of
1934.
|
|
2.
|
|
One signed original and four conformed copies of this form and
amendments thereto must be completed and filed with the Securities and
Exchange Commission, Washington, D.C. 20549, in accordance with Rule
0-3 of the General Rules and Regulations under the Act. The
information contained in or filed with the form will be made a matter
of public record in the Commission files.
|
|
3.
|
|
A manually signed copy of the form and amendments thereto shall be
filed with each national securities exchange on which any class of
securities of the registrant is registered.
|
|
4.
|
|
Amendments to the notifications must also be filed on Form 12b-25 but
need not restate information that has been correctly furnished. The
form shall be clearly identified as an amended notification.
|
|
5.
|
|
Electronic Filers:
This form shall not be used by electronic filers
unable to timely file a report solely due to electronic difficulties.
Filers unable to submit reports within the time period prescribed due
to difficulties in electronic filing should comply with either Rule
201 or Rule 202 of Regulation S-T (§232.201 or §232.202 of this
chapter) or apply for an adjustment in filing date pursuant to Rule
13(b) of Regulation S-T (§232.13(b) of this chapter).
|
Escalon Medical (QB) (USOTC:ESMC)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Escalon Medical (QB) (USOTC:ESMC)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024